Both in Pharmaceuticals
Q32 Bio vs Rocket Pharmaceuticals
Over the past year QTTB returned +222.8% and RCKT returned −34.1%; their daily moves had a correlation of 0.06.
QTTB +222.8% RCKT −34.1%Growth of $1, one year, split-adjusted
| Metric | QTTB | RCKT |
|---|---|---|
| Price | $8.91 | $2.44 |
| Market cap | $265.2M | $267.9M |
| Today | +0.45% | −3.94% |
| 1 month | +8.0% | −5.8% |
| 6 months | +76.8% | −31.5% |
| Year to date | +168.4% | −30.5% |
| 1 year | +232.5% | −35.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 7.9× | — |
| Price / sales | 4.9× | — |
| Net cash | $106.3M | $262.5M |
| Dividend yield | — | — |
| Volatility (60d) | 62.9% | 66.4% |
| Short % of float | 32.6% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).